Company / R&D Expense
BioAtla, Inc. R&D Expense History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$79.3M
FY2022
5-year range
$58.3M / $79.3M
FY2021-FY2022
Trend
+36.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$79M in FY2022.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, r&d expense increased 36.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.29 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $79.3M | +36.2% |
| FY2021 | $58.3M | - |
As of FY2022 · SEC Form 10-K · Last checked Jun 21, 2026